Extract from Staff Matters 27/10
Men’s health will be in the spotlight at the trust’s next Health Matters public lecture.
The free event will cover prostate and testicular cancer in reference to Movember – the themed month which encourages men to grow moustaches to help raise awareness of male health issues.
The talk, which takes place on Tuesday, November 4th, will be delivered by Dr Steve Bromage – a consultant urological surgeon with Stockport NHS Foundation Trust, which also provides urology services at Macclesfield Hospital.
Trust staff are welcome to attend the event but places are limited, so please book in advance by contacting the Communications and Engagement Department on freephone 0800 195 4194 or email firstname.lastname@example.org
Extract from BMJ Learning
BMJ Learning modules – have you done this one yet on Prostate Cancer?
One of your patients is an 85 year old man who has recently been diagnosed with intermediate risk, localised prostate cancer. The hospital has suggested a watchful waiting strategy for his management. He understands that the main advantage of watchful waiting is that there will be no physical side effects of treatment. However he wonders if there are any disadvantages of this strategy. What would you say to him? What if he didn’t want to follow the advice given? If you would like to learn more about this topic, then click on the link to complete this module today.
Prostate cancer: understanding the patient pathway and treatment options – in association with Prostate Cancer UK
And here are their most popular modules in respiratory medicine for you to complete.
An 84 year old woman is having trouble sleeping at night. This has been a recurring problem for some months. You know she has had a fall earlier this year. She wants some medication to help her sleep as she feels that this is affecting her ability to do things during the day. What would you advise? What if she didn’t want to follow your advice? If you would like to learn more about this topic, then click on the link to complete this module today.
Falls in older people: prevention and management
And here are our most popular modules in urology for you to complete.
Idiopathic constipation and nocturnal enuresis in childhood: a guide to management – in association with NICE
Lower urinary tract symptoms in men: a guide to management – in association with NICE
Erectile dysfunction: diagnosis and treatment
Managing patients at risk of prostate cancer: in association with the NHS prostate cancer management programme
Urinary tract infection in children: diagnosis, treatment, and long term management – in association with NICE
March is Prostate Cancer Awareness month and listed below are a number of useful websites, where additional information and resources may be found. If you require assistance with researching this or any other topics, please contact the Staff Library on 01625 66 1362 or by email to email@example.com
eResources and websites:
Cancer Research UK (Prostate Cancer)
The websites on cancer listed below are valuable sources of detailed information on cancer. This is an extract from Cancer Research UK
Prostate Cancer UK
U-turn on NHS prostate drug use
A drug for advanced prostate cancer, which can extend life by more than three months, is likely to be approved for NHS use in England and Wales after the medical watchdog reverses an earlier decision.
Vitamin E supplementation and prostate cancer risk
SELECT trial finds no reduction and suggests an increase in risk of prostate cancer with either selenium or vitamin E supplements.
Health professionals express a need for more training to deal with third party interpreting for cancer patients.
There is insufficient evidence to support the use of combination therapy to treat chronic kidney disease.
The evidence base continues to build, suggesting that daily aspirin can be used to prevent cancer.
Details of a new resource available via NHS Evidence search.
Athens account required
BMJ 2012; 344 doi: 10.1136/bmj.e3252 (Published 8 May 2012)
Cite this as: BMJ 2012;344:e3252
The latest figures show that the number of men in the United Kingdom receiving a diagnosis of prostate cancer has risen to more than 40 000 a year, mainly because of greater use of prostate specific antigen (PSA) testing.
Cancer Research UK reported that 40 841 cases of prostate cancer were recorded in 2009, the most recent year for which incidence figures are available. The data were collected by regional cancer registries in England and the three national cancer registries in Wales, Scotland, and Northern Ireland.
via Latest UK figures show increase in prostate cancer diagnoses and falling death rate | BMJ.
A life-extending drug hailed as a breakthrough for prostate cancer sufferers is too expensive to be used on the NHS, watchdogs ruled today.
Cabazitaxel, which is marketed as Jevtana, can extends the life of late-stage patients by an average of three months.
via Anger as NHS deem prostate cancer drug Cabazitaxel ‘too expensive’ – Health News – Health & Families – The Independent.